| Literature DB >> 27581346 |
Noriyuki Ouchi1, Koji Ohashi, Rei Shibata, Toyoaki Murohara.
Abstract
Obesity is a major risk factor for progression of cardiovascular disease. Adipose tissue is recognized as an endocrine organ producing various secretory molecules, also known as adipocytokines, and dysregulated production of adipocytokines participates in the pathogenesis of obesity complications, including metabolic dysfunction and cardiovascular disorders. Recent evidence indicates that skeletal muscle also functions as an endocrine organ capable of secreting a number of bioactive substances, also referred to as myokines. Several myokines are involved in metabolic and cardiovascular regulation. This review will discuss the clinical and experimental studies that have investigated the protective role of several adipocytokines and myokines in cardiovascular diseases. (Circ J 2016; 80: 2073-2080).Entities:
Mesh:
Substances:
Year: 2016 PMID: 27581346 DOI: 10.1253/circj.CJ-16-0663
Source DB: PubMed Journal: Circ J ISSN: 1346-9843 Impact factor: 2.993